221 related articles for article (PubMed ID: 34093865)
1. Improving the sensitivity of
Yang L; Wang L; Huang G; Zhang X; Chen L; Li A; Gao J; Zhou Z; Su L; Yang H; Song J
Theranostics; 2021; 11(14):6966-6982. PubMed ID: 34093865
[No Abstract] [Full Text] [Related]
2. Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive
Wei R; Liu K; Zhang K; Fan Y; Lin H; Gao J
ACS Appl Mater Interfaces; 2022 Jan; 14(3):3784-3791. PubMed ID: 35019261
[TBL] [Abstract][Full Text] [Related]
3. MnO-labeled cells: positive contrast enhancement in MRI.
Létourneau M; Tremblay M; Faucher L; Rojas D; Chevallier P; Gossuin Y; Lagueux J; Fortin MA
J Phys Chem B; 2012 Nov; 116(44):13228-38. PubMed ID: 23030472
[TBL] [Abstract][Full Text] [Related]
4. One-pot preparation of hydrophilic manganese oxide nanoparticles as T
Li J; Wu C; Hou P; Zhang M; Xu K
Biosens Bioelectron; 2018 Apr; 102():1-8. PubMed ID: 29101783
[TBL] [Abstract][Full Text] [Related]
5. Fabrication and evaluation of tumor-targeted positive MRI contrast agent based on ultrasmall MnO nanoparticles.
Huang H; Yue T; Xu K; Golzarian J; Yu J; Huang J
Colloids Surf B Biointerfaces; 2015 Jul; 131():148-54. PubMed ID: 25982318
[TBL] [Abstract][Full Text] [Related]
6. Tuning the size and composition of manganese oxide nanoparticles through varying temperature ramp and aging time.
Martinez de la Torre C; Grossman JH; Bobko AA; Bennewitz MF
PLoS One; 2020; 15(9):e0239034. PubMed ID: 32946514
[TBL] [Abstract][Full Text] [Related]
7. MnO nanoparticles with unique excitation-dependent fluorescence for multicolor cellular imaging and MR imaging of brain glioma.
Lai J; Wang T; Wang H; Shi F; Gu W; Ye L
Mikrochim Acta; 2018 Apr; 185(4):244. PubMed ID: 29610993
[TBL] [Abstract][Full Text] [Related]
8. pH-Activatable MnO-Based Fluorescence and Magnetic Resonance Bimodal Nanoprobe for Cancer Imaging.
Hsu BY; Ng M; Tan A; Connell J; Roberts T; Lythgoe M; Zhang Y; Wong SY; Bhakoo K; Seifalian AM; Li X; Wang J
Adv Healthc Mater; 2016 Mar; 5(6):721-9. PubMed ID: 26895111
[TBL] [Abstract][Full Text] [Related]
9. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles.
Na HB; Lee JH; An K; Park YI; Park M; Lee IS; Nam DH; Kim ST; Kim SH; Kim SW; Lim KH; Kim KS; Kim SO; Hyeon T
Angew Chem Int Ed Engl; 2007; 46(28):5397-401. PubMed ID: 17357103
[No Abstract] [Full Text] [Related]
10. In Vivo Dual-Modality Fluorescence and Magnetic Resonance Imaging-Guided Lymph Node Mapping with Good Biocompatibility Manganese Oxide Nanoparticles.
Zhan Y; Zhan W; Li H; Xu X; Cao X; Zhu S; Liang J; Chen X
Molecules; 2017 Dec; 22(12):. PubMed ID: 29231865
[TBL] [Abstract][Full Text] [Related]
11. Cy5.5 conjugated MnO nanoparticles for magnetic resonance/near-infrared fluorescence dual-modal imaging of brain gliomas.
Chen N; Shao C; Li S; Wang Z; Qu Y; Gu W; Yu C; Ye L
J Colloid Interface Sci; 2015 Nov; 457():27-34. PubMed ID: 26151564
[TBL] [Abstract][Full Text] [Related]
12. Folic acid-conjugated MnO nanoparticles as a T1 contrast agent for magnetic resonance imaging of tiny brain gliomas.
Chen N; Shao C; Qu Y; Li S; Gu W; Zheng T; Ye L; Yu C
ACS Appl Mater Interfaces; 2014 Nov; 6(22):19850-7. PubMed ID: 25335117
[TBL] [Abstract][Full Text] [Related]
13. Manganese Oxide Nanoparticle Synthesis by Thermal Decomposition of Manganese(II) Acetylacetonate.
Martinez de la Torre C; Bennewitz MF
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32628168
[TBL] [Abstract][Full Text] [Related]
14. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
[TBL] [Abstract][Full Text] [Related]
15. Bifunctional Pyrrolidin-2-one Terminated Manganese Oxide Nanoparticles for Combined Magnetic Resonance and Fluorescence Imaging.
Banerjee A; Bertolesi GE; Ling CC; Blasiak B; Purchase A; Calderon O; Tomanek B; Trudel S
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13069-13078. PubMed ID: 30883086
[TBL] [Abstract][Full Text] [Related]
16. HSA coated MnO nanoparticles with prominent MRI contrast for tumor imaging.
Huang J; Xie J; Chen K; Bu L; Lee S; Cheng Z; Li X; Chen X
Chem Commun (Camb); 2010 Sep; 46(36):6684-6. PubMed ID: 20730157
[TBL] [Abstract][Full Text] [Related]
17. MnO nanoparticles with potential application in magnetic resonance imaging and drug delivery for myocardial infarction.
Zheng Y; Zhang H; Hu Y; Bai L; Xue J
Int J Nanomedicine; 2018; 13():6177-6188. PubMed ID: 30323598
[TBL] [Abstract][Full Text] [Related]
18. Water-soluble and biocompatible MnO@PVP nanoparticles for MR imaging in vitro and in vivo.
Hu X; Ji Y; Wang M; Miao F; Ma H; Shen H; Jia N
J Biomed Nanotechnol; 2013 Jun; 9(6):976-84. PubMed ID: 23858961
[TBL] [Abstract][Full Text] [Related]
19. Water-soluble MnO nanocolloid for a molecular T1 MR imaging: a facile one-pot synthesis, in vivo T1 MR images, and account for relaxivities.
Baek MJ; Park JY; Xu W; Kattel K; Kim HG; Lee EJ; Patel AK; Lee JJ; Chang Y; Kim TJ; Bae JE; Chae KS; Lee GH
ACS Appl Mater Interfaces; 2010 Oct; 2(10):2949-55. PubMed ID: 20929249
[TBL] [Abstract][Full Text] [Related]
20. Polyglycerol grafting and RGD peptide conjugation on MnO nanoclusters for enhanced colloidal stability, selective cellular uptake and cytotoxicity.
Yang X; Zhao L; Zheng L; Xu M; Cai X
Colloids Surf B Biointerfaces; 2018 Mar; 163():167-174. PubMed ID: 29291502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]